How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Upper and Lower Extremity Suture Anchor Market
- By Anchor Material: Titanium, Bioabsorbable Polymer, PEEK (Polyether Ether Ketone), Composite Materials, Stainless Steel
- By Anchor Type: Suture Anchor, Interference Screw, Soft Tissue Anchor, Push-In Anchor, Swivelock Anchor
- By Suture Type: Non-absorbable Polyester, Ultra-High Molecular Weight Polyethylene (UHMWPE), Absorbable Polydioxanone (PDO), Braided Polyester, Monofilament Nylon
- By Application: Rotator Cuff Repair, Labral Repair, Ligament Reconstruction, Tendon Repair, Fracture Fixation
- By Surgical Technique: Arthroscopic, Open Surgery, Mini-Open
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Titanium leads By Anchor Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Upper and Lower Extremity Suture Anchor Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Anchor Material 5
Anchor Type 5
Suture Type 5
Application 5
Surgical Technique 3
Companies profiled
DePuy Synthes (Johnson & Johnson)
Arthrex Inc.
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings Inc.
CONMED Corporation
DJO Global (Colfax Corporation)
Mitek Sports Medicine (Johnson & Johnson)
B. Braun Melsungen AG
Wright Medical Group N.V. (Stryker)
Linvatec Corporation (a division of Smith & Nephew)
RTI Surgical Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Arthrex Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →CONMED Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →DJO Global (Colfax Corporation)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Mitek Sports Medicine (Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Wright Medical Group N.V. (Stryker)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Linvatec Corporation (a division of Smith & Nephew)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →RTI Surgical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Acumed LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Integra LifeSciences Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Orthofix International N.V.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,012M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Titanium37.8
- Bioabsorbable Polymer19.2
- PEEK (Polyether Ether Ketone)18.1
- Composite Materials13.7
- Stainless Steel11.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$693.8M → $1,112M · 6.1%
Europe$483.5M → $671.5M · 4.2%
Asia Pacific$441.5M → $591.9M · 3.7%
Latin America$273.3M → $427.0M · 5.7%
Middle East and Africa$210.2M → $304.9M · 4.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.562026
4.572027
4.562028
4.592029
4.592030
4.602031
4.632032
4.632033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- DePuy Synthes (Johnson & Johnson)20.9
- Arthrex Inc.12.4
- Smith & Nephew plc13.6
- Stryker Corporation12.2
- Zimmer Biomet Holdings Inc.7.9
- CONMED Corporation4.9
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Anchor Material25.5%
Anchor Type22.5%
Suture Type16.9%
Application13.6%
Surgical Technique21.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.8
- Europe21.6
- Asia Pacific19.0
- Latin America13.7
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| DePuy Synthes (Johnson & Johnson) | 90 | 85 | 77 | 75 | 73 | 97 | 83 |
| Arthrex Inc. | 75 | 89 | 82 | 80 | 74 | 71 | 79 |
| Smith & Nephew plc | 79 | 74 | 69 | 68 | 78 | 66 | 72 |
| Stryker Corporation | 78 | 68 | 71 | 64 | 63 | 78 | 70 |
| Zimmer Biomet Holdings Inc. | 54 | 74 | 62 | 73 | 62 | 64 | 65 |
| CONMED Corporation | 63 | 66 | 59 | 47 | 67 | 63 | 61 |
| DJO Global (Colfax Corporation) | 44 | 58 | 64 | 54 | 43 | 65 | 55 |
| Mitek Sports Medicine (Johnson & Johnson) | 38 | 35 | 60 | 54 | 50 | 46 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- DePuy Synthes (Johnson & Johnson)
- Arthrex Inc.
- Smith & Nephew plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| DePuy Synthes (Johnson & Johnson) | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Arthrex Inc. | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Smith & Nephew plc | ✓ | − | ◐ | ✓ | ◐ | − |
| Stryker Corporation | ✓ | ◐ | − | ✓ | ◐ | ✓ |
| Zimmer Biomet Holdings Inc. | − | − | ◐ | ✓ | − | − |
| CONMED Corporation | ◐ | ◐ | − | − | − | − |
| DJO Global (Colfax Corporation) | − | − | − | ◐ | − | ◐ |
| Mitek Sports Medicine (Johnson & Johnson) | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1DePuy Synthes (Johnson & Johnson)83
2Arthrex Inc.79
3Smith & Nephew plc72
4Stryker Corporation70
5Zimmer Biomet Holdings Inc.65
6CONMED Corporation61
7DJO Global (Colfax Corporation)55
8Mitek Sports Medicine (Johnson & Johnson)47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
DePuy Synthes (Johnson & Johnson)Arthrex Inc.
Challenger2
Strong scale, closing on the leaders.
Smith & Nephew plcStryker Corporation
Contender2
Focused players with pockets of strength.
Zimmer Biomet Holdings Inc.CONMED Corporation
Niche2
Specialists in a single segment or region.
DJO Global (Colfax Corporation)Mitek Sports Medicine (Johnson & Johnson)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Anchor Material in North America, then scale across Upper and Lower Extremity Suture Anchor Market — a $328M beachhead inside a $4.64B market.
Beachhead (SOM)$328Mobtainable near-term
Serviceable (SAM)$1.73Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Titanium
Best fit — highest urgency & budget in Anchor Material.
Economic buyer79 fit
Bioabsorbable Polymer
Strong fit — clear ROI and a fast path to value.
End user65 fit
PEEK (Polyether Ether Ketone)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Anchor Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Anchor Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Suture Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Anchor Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Upper and Lower Extremity Suture Anchor Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified26%
Evaluation13%
Closed-won5%
$14.0KCAC
$48KLTV
3.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Upper and Lower Extremity Suture Anchor Market is a resilient opportunity — $4.25B by 2033, compounding at 4.8%.
TAM · 2025$2.93Btoday
TAM · 2033$4.25Bforecast
CAGR4.8%2027–2033
Cumulative$32.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.25BTotal addressable market
SAM$1.68BServiceable available market
SOM$365MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Anchor Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Anchor Material moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.25BLarge & growingTAM by 2033 at 4.8% CAGR
$1.68BServiceable nowreachable with today’s model
$365MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.32BBear3.1% CAGR
$4.25BBase4.8% CAGR
$5.44BBull6.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Anchor Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Upper and Lower Extremity Suture Anchor Market — a $7.33B market by 2033. Plan: grow share from 9.6% to 14.9%.
Market size · 2033$7.33Btotal addressable
Market CAGR6.7%2027–2033
Target share14.9%from 9.6% today
Revenue ambition$1.09Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.6% | 14.9% | On track |
| Revenue | $693M | $1.09B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.5% | 41.6% | At risk |
| Customer retention | 90.6% | 93.7% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Anchor Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Anchor Type capability
A defensible second engine — invest in Anchor Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Anchor Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Anchor Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $154M capacity & capability investment
- Greenlight bolt-on M&A in Anchor Type
- Authorise North America expansion plan
- Fund R&D program for Anchor Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Upper and Lower Extremity Suture Anchor Market conversation — a $6.44B market you can size, segment and defend in minutes.
Market size · 2033$6.44Btotal opportunity
Growth10.8%CAGR to 2033
Addressable buyers1,663+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Anchor Material
Goal Grow share in Anchor Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 2 mopayback period
$78K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
DePuy Synthes (Johnson & Johnson)Arthrex Inc.Smith & Nephew plcStryker CorporationZimmer Biomet Holdings Inc.CONMED CorporationDJO Global (Colfax Corporation)Mitek Sports Medicine (Johnson & Johnson)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Upper and Lower Extremity Suture Anchor Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Upper and Lower Extremity Suture Anchor Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Upadacitinib Market
Market size, share, segmentation and regional forecast.
$533M market · 2025 base year
View reportUnweighing Gait Trainers Market
Market size, share, segmentation and regional forecast.
$758M market · 2025 base year
View reportUnresectable Hepatocellular Carcinoma Treatment Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportUniversal Surgical Pack Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportUniversal Supplementary Medical Insurance Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportUniversal PRP Centrifuge Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportUniversal Pipette Tip Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportUniversal Pathogen Kit Market
Market size, share, segmentation and regional forecast.
$889M market · 2025 base year
View reportUniversal Lateral Flow Assay (LFA) Kits Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportUniversal Lateral Flow Assay Kit Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportUniversal Electrosurgical Unit Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportUniversal Curettes Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.